BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20280401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20280930T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260916T170000
DTEND;TZID=Australia/Sydney:20260916T170000
DTSTAMP:20260602T045957Z
CREATED:20260602T045957Z
LAST-MODIFIED:20260602T045957Z
UID:10000300-1789578000-1789578000@melanoma.org.au
SUMMARY:MRFF International Clinical Trial Collaborations
DESCRIPTION:The objective of the Medical Research Future Fund (MRFF) – 2026 International Clinical Trial Collaborations Grant Opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \n\nPromote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.\nProvide high-quality evidence of the effectiveness of novel health treatments\, drugs or devices in ‘usual care’ settings\, which will support a decision on whether to deliver the intervention in an Australian setting.\n\nThe anticipated outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality\, evidence-based and effective health care. \nPlease note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only. \n\nKey Dates:\nMinimum data due: 19 August 2026\nApplications close: 16 September 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-int-clinical-trial-collaborations/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-International-Clinical-Trial-Collaborations-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20270331T170000
DTEND;TZID=Australia/Sydney:20270331T170000
DTSTAMP:20260618T051009Z
CREATED:20260618T051009Z
LAST-MODIFIED:20260618T051009Z
UID:10000310-1806512400-1806512400@melanoma.org.au
SUMMARY:MRFF 2022 Frontier Health and Medical Research Grant
DESCRIPTION:This grant program will support researchers to pursue big ideas to develop new products and interventions and implement these into clinical practice\, benefiting patients\, clinicians\, and the health system. \nThis grant opportunity offers funding to support medical research and medical innovation programs of research (up to $25 million per program) that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition\, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re‑purpose existing health technologies in a novel way. \nThe initial application process to secure funding through this grant opportunity will be conducted in two stages: \n\nexpression of interest (EOI) – outlining a proposed program of research comprising of a series of linked projects with a 10-year time horizon\nfull application\, (invitation only – following EOI) for a project of up to 5 years under the program of research.\n\nApplicants may propose to commence research at any stage in the research pipeline from proof-of-concept\, with the intention of achieving full implementation of the proposed technology in 10 years. \nFunding for subsequent projects under the program of research that continue to progress the technology towards full implementation can be sought by submitting additional full applications to this grant opportunity (i.e. applicants do not need to recommence with an EOI). These applications may be submitted by invitation only. \n\nKey Dates:\nExpressions of Interest close: 31 March 2027\nLast grants awarded by: 30 June 2028 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-2022-frontier-grant/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/MRFF-2022-Frontier-Health-and-Medical-Research-Grant-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR